Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-01 15:18:11 - browse：64

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： FDA moves to stop vape shops from selling Elf Bar, Esco Bars

WSS

Secretariat’s lessons for human medicine

How dance can help nurses traumatized by Covid

Group opposing PBM reform sets lobbying record

WATCH: Why do our ears pop?

In early work, researchers turn to CRISPR to treat Alzheimer's

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

focus

Wikipedia

hotspot

Hollywood unions extend contract negotiations for actors

Medicare has a new plan to address drug shortages

The cancer drug shortage isn’t new — and neither are the solutions

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Psychedelics group wrestles with new pharma identity

Secretariat’s lessons for human medicine

What does generative AI mean for health care? We asked experts

Why hospitals are withdrawing from US News rankings

Medicare proposal to cover medical devices draws a mixed reaction

Weight loss drugs aren’t covered by Obamacare. That may change

Wikipedia

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Hospitals are piloting generative AI tools as regulators play catch

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Weight loss drugs aren’t covered by Obamacare. That may change

MD Anderson's Padmanee Sharma responds to research credit suit

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

hotspot

hotspot

hotspot

hotspot